Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain.

Pilar H García-CasanovaPablo Pérez-MartínezTeresa SevillaRosalía DoménechMontserrat LeónJuan Francisco Vázquez Costa

Published in: European journal of neurology (2024)

This study shows a high risk of severe COVID-19 amongst ALS patients requiring NIV. Nevertheless, the pandemic showed no impact in the overall survival of ALS patients, probably due to a high vaccination rate and an adequate access to healthcare resources.

Keyphrases

end stage renal disease
healthcare
amyotrophic lateral sclerosis
ejection fraction
chronic kidney disease
newly diagnosed
sars cov
prognostic factors
peritoneal dialysis
patient reported outcomes
early onset
patient reported
health insurance